Bioworkshop
Bioworkshop provides an end-to-end platform that speeds drug discovery and preclinical development using in silico screening and high-fidelity human models for in vitro validation. The core technology combines AI/machine learning, 3D-printed microfluidic biochips, and knowledge maps to simulate and test potential drug candidates. It supports rapid lead identification and optimization within established R&D workflows and enables in vitro testing on human-relevant models to improve prediction accuracy. The platform is designed to integrate with standard research data pipelines and decision processes, reducing time and cost in preclinical stages. The focus includes age-related disorders, with the goal of scalable, larger-scale collaborations in biotech and pharma.
Bioworkshop
Bioworkshop provides an end-to-end platform that speeds drug discovery and preclinical development using in silico screening and high-fidelity human models for in vitro validation. The core technology combines AI/machine learning, 3D-printed microfluidic biochips, and knowledge maps to simulate and test potential drug candidates. It supports rapid lead identification and optimization within established R&D workflows and enables in vitro testing on human-relevant models to improve prediction accuracy. The platform is designed to integrate with standard research data pipelines and decision processes, reducing time and cost in preclinical stages. The focus includes age-related disorders, with the goal of scalable, larger-scale collaborations in biotech and pharma.